In Focus: sustainability in cell and gene therapy
The advanced therapies and pharmaceuticals industry are under constant pressure to innovate. With the common goal of bringing life-saving treatments to patients, the industry often overlooks its profound environmental impact. How can we ensure a sustainable future in cell and gene therapy?
In this In Focus feature, we explore how the cell and gene therapy industry can develop and scale products more sustainably. Experts at Nucleus Biologics (CA, USA) also discuss how point-of-use manufacturing could reduce the environmental footprint of cell culture media, all while improving quality, cost-effectiveness and downstream scalability.
Infographic
Sustainability in CGT: can cell and gene therapy developers save the environment, while saving patients? – From reducing plastic pollution in labs to slashing carbon from manufacturing processes, the cell and gene therapy industry must find ways to develop therapies in an environmentally responsible manner. In this infographic, which has been created by RegMedNet in association with Nucleus Biologics (CA, USA), discover the ways that developers can revolutionize their workflows to streamline the pharmaceutical industry into a cleaner and greener future.
Interview
Sustainability in cell and gene therapy: an interview with Roddy O’Connor – Can pharmaceutical products be both sustainable and convenient? Roddy O’Connor argues that they must. In this interview with Dr O’Connor, we explore his research into CAR-T metabolism for solid tumors and the importance of sustainability in the lab. His research relies on the ability to customize media formulations to gain insight into individual component impacts on cellular metabolism. Roddy discusses his experience with Nucleus Biologics’ Krakatoa system and its contribution towards a cleaner planet for future generations.
Resources
3 ways to improve sustainability in advanced therapies
Krakatoa Media Maker – The World’s First Pod-Based Cell Culture Media Maker
In association with
